Monica Sonzogni

contact

  • m.sonzogni@erasmusmc.nl
  • +31 010 70 37339
  • Room: Ee-1493
  • Dr. Molewaterplein 40, Faculty Building, Rotterdam, The Netherlands

Monica Sonzogni (M.)

  • Position: Phd Student, Erasmus MC

Publications

1. UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.

Elgersma Y, Sonzogni M
in Developmental medicine and child neurology 2021
DOI: 10.1111/dmcn.14831

2. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.

Sonzogni M, Zhai P, Mientjes EJ, van Woerden GM, Elgersma Y
in Molecular autism 2020
DOI: 10.1186/s13229-020-00376-9

3. Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms.

Zampeta IF, Sonzogni M, Niggl E, Lendemeijer B, Smeenk H, de Vrij FMS, Kushner SA, Distel B, Elgersma Y
in Human molecular genetics 2020
DOI: 10.1093/hmg/ddaa194

4. Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.

Avagliano Trezza R, Sonzogni M, Bossuyt SNV, Zampeta FI, Punt AM, van den Berg M, Rotaru DC, Koene LMC, Munshi ST, Stedehouder J, Kros JM, Williams M, Heussler H, de Vrij FMS, Mientjes EJ, van Woerden GM, Kushner SA, Distel B, Elgersma Y
in Nature neuroscience 2019
DOI: 10.1038/s41593-019-0425-0

5. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.

Sonzogni M, Hakonen J, Bernabé Kleijn M, Silva-Santos S, Judson MC, Philpot BD, van Woerden GM, Elgersma Y
in Molecular autism 2019
DOI: 10.1186/s13229-019-0277-1

6. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel mutants.

Sonzogni M, Wallaard I, Santos SS, Kingma J, du Mee D, van Woerden GM, Elgersma Y
in Molecular autism 2018
DOI: 10.1186/s13229-018-0231-7
show more publications